Cargando…
Heat Shock Proteins in Lymphoma Immunotherapy
Immunotherapy harnessing the host immune system for tumor destruction revolutionized oncology research and advanced treatment strategies for lymphoma patients. Lymphoma is a heterogeneous group of cancer, where the central roles in pathogenesis play immune evasion and dysregulation of multiple signa...
Autores principales: | Albakova, Zarema, Mangasarova, Yana, Sapozhnikov, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012763/ https://www.ncbi.nlm.nih.gov/pubmed/33815422 http://dx.doi.org/10.3389/fimmu.2021.660085 |
Ejemplares similares
-
Impaired Heat Shock Protein Expression in Activated T Cells in B-Cell Lymphoma
por: Albakova, Zarema, et al.
Publicado: (2022) -
Heat Shock Proteins in Urine as Cancer Biomarkers
por: Albakova, Zarema, et al.
Publicado: (2021) -
Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients
por: Albakova, Zarema, et al.
Publicado: (2022) -
The HSP Immune Network in Cancer
por: Albakova, Zarema, et al.
Publicado: (2021) -
The Role of Heat Shock Protein 70 kDa in Asthma
por: Shevchenko, Marina, et al.
Publicado: (2021)